Trial intelligence / Profile preview

Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis

NCT05721404Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Sun Yat-sen University
Start
May 2023
Primary completion
Apr 2027
Modality
Polymer-based Nanoparticles, Device-based Delivery
Countries
1
01

Overview

A Phase 4 trial of icodextrin in Fluid overload, sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started May 2023; status: recruiting.

02

Drugs

icodextrin
03

Conditions

Fluid overload

Beyond the preview

Go deeper on NCT05721404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05721404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call